Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...
News Medical on MSN23h
Scientists pinpoint metabolic failure as the cause of muscle loss in agingA multi-omics study reveals that impaired branched-chain amino acid (BCAA) catabolism is a key driver of sarcopenia, ...
A new editorial was published in Volume 16, Issue 22 of Aging (Aging-US) on December 11, 2024, titled “ISarcoPRM algorithm for global operationalization of sarcopenia diagnosis.” ...
Researchers at The University of Texas MD Anderson Cancer Center have identified a potential breakthrough in the fight ...
The high prevalence of sarcopenia in patients with ovarian and endometrial cancers underscores the importance of early ...
The sarcopenia treatment market is estimated to be $3.07 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 4.48% and is estimated to reach $4.02 billion by 2029.
Weight-loss drugs have helped many people lose excess weight, but for some, rapid weight loss comes with a hidden risk—the ...
SALT LAKE CITY - Lipocine Inc. (NASDAQ: NASDAQ:LPCN), a biopharmaceutical company with a market capitalization of approximately $24 million, announced today that it will conduct a phase 3 safety and ...
Autophagy is the process by which cells digest and renew their internal structures, recycling damaged or malfunctioning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback